triazolam has been researched along with Headache in 2 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Headache: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Greenblatt, DJ | 1 |
Shader, RI | 1 |
Divoll, M | 1 |
Harmatz, JS | 1 |
Olson, KR | 1 |
Yin, L | 1 |
Osterloh, J | 1 |
Tani, A | 1 |
1 trial available for triazolam and Headache
Article | Year |
---|---|
Adverse reactions to triazolam, flurazepam, and placebo in controlled clinical trials.
Topics: Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Dizziness; Dose-Response Relationship, Drug; D | 1984 |
1 other study available for triazolam and Headache
Article | Year |
---|---|
Coma caused by trivial triazolam overdose.
Topics: Adult; Anti-Anxiety Agents; Coma; Female; Headache; Humans; Sleep Initiation and Maintenance Disorde | 1985 |